•  8
    Umbrella and basket trials in oncology: ethical challenges
    with Karolina Strzebonska
    BMC Medical Ethics 20 (1): 1-10. 2019.
    Novel precision oncology trial designs, such as basket and umbrella trials, are designed to test new anticancer agents in more effective and affordable ways. However, they present some ethical concerns referred to scientific validity, risk-benefit balance and informed consent. Our aim is to discuss these issues in basket and umbrella trials, giving examples of two ongoing cancer trials: NCI-MATCH and Lung-MAP study. We discuss three ethical requirements for clinical trials which may be challenge…Read more
  •  4
    Underestimation of Harms in Phase I Trials
    with Karolina Strzebonska
    Journal of Law, Medicine and Ethics 47 (2): 334-335. 2019.
  •  17
    Neither the Harm Principle nor the Best Interest Standard Should Be Applied to Pediatric Research
    with Karolina Strzebonska and Mateusz T. Wasylewski
    American Journal of Bioethics 18 (8): 72-74. 2018.
  •  3
    Publication Ethics in Biomedical Journals from Countries in Central and Eastern Europe
    with Mindaugas Broga, Goran Mijaljica, Aime Keis, and Ana Marusic
    Science and Engineering Ethics 20 (1): 99-109. 2014.
    Publication ethics is an important aspect of both the research and publication enterprises. It is particularly important in the field of biomedical science because published data may directly affect human health. In this article, we examine publication ethics policies in biomedical journals published in Central and Eastern Europe. We were interested in possible differences between East European countries that are members of the European Union and South-East European countries that are not member…Read more
  •  373
    Publication Ethics in Biomedical Journals from Countries in Central and Eastern Europe
    with Mindaugas Broga, Goran Mijaljica, Aime Keis, and Ana Marusic
    Science and Engineering Ethics (1): 1-11. 2013.
    Publication ethics is an important aspect of both the research and publication enterprises. It is particularly important in the field of biomedical science because published data may directly affect human health. In this article, we examine publication ethics policies in biomedical journals published in Central and Eastern Europe. We were interested in possible differences between East European countries that are members of the European Union (Eastern EU) and South-East European countries (South…Read more
  •  189
    Failures in Clinical Trials in the European Union: Lessons from the Polish Experience
    Science and Engineering Ethics 19 (3): 1087-1098. 2013.
    When discussing the safety of research subjects, including their exploitation and vulnerability as well as failures in clinical research, recent commentators have focused mostly on countries with low or middle-income economies. High-income countries are seen as relatively safe and well-regulated. This article presents irregularities in clinical trials in an EU member state, Poland, which were revealed by the Supreme Audit Office of Poland (the NIK). Despite adopting many European Union regulatio…Read more
  • Oswajanie Lacana
    Principia. 2006.
  •  19
    Research in disaster settings: a systematic qualitative review of ethical guidelines
    with Signe Mezinska, Péter Kakuk, Goran Mijaljica, and Dónal P. O’Mathúna
    BMC Medical Ethics 17 (1): 62. 2016.
    Conducting research during or in the aftermath of disasters poses many specific practical and ethical challenges. This is particularly the case with research involving human subjects. The extraordinary circumstances of research conducted in disaster settings require appropriate regulations to ensure the protection of human participants. The goal of this study is to systematically and qualitatively review the existing ethical guidelines for disaster research by using the constant comparative meth…Read more
  •  28
    A European consistency for functioning of RECs? We just lost our chance
    Journal of Medical Ethics 39 (6): 408-409. 2013.
    On 17 July 2012, the European Commission formally adopted a proposal for a new European Union (EU) Directive regarding clinical trials, which will repeal and replace the existing Directive 2001/20/EC. The main reasons for the revision were: (1) the decreasing number of clinical trials in the region and (2) harsh criticism of the present version of the Directive. The proposed regulation could simplify the rules for conducting clinical trials and also rebuild the entire system of clinical trial as…Read more
  • The aim of this article is to present a critical overview of Jacques Derrida’s objections to the theories of phenomenological experience. I present and analyze Derrida’s principal arguments which show that the primordial character of such experiences is only apparent. I also try to sketch a possible line of defense and to undermine some of the interpretational presuppositions introduced by the author of La voix et le phénomène